- Home
- Oncology latest news
Oncology latest news
Below you’ll find the most recent oncology news across Johnson & Johnson.
Janssen Data at ASCO GU Demonstrate Longstanding Leadership in Prostate Cancer and Commitment to Advancing Potential New Therapeutic Options for Genitourinary Cancers
Initial results from Phase 3 MAGNITUDE study of niraparib in combination with abiraterone acetate plus prednisone as a first-line therapy in patients with metastatic castration-resistant prostate cancer featured as an oral presentation New data for ERLEADA® (apalutamide) build on more than a decade of experience in prostate cancer; updated clinical trial information for novel drug delivery system TAR-200 plus cetrelimab in early-stage bladder cancer to be presented
News Archive
Looking for more news? Visit the archive to see a full list of oncology updates from the past several years.
More from Johnson & Johnson
New Year, new vision: Meet a man tasked with investing in what could be the world’s next great medical discoveries
Johnson & Johnson aspires to change the trajectory of health for humanity. And Tom Heyman helps make that lofty goal a reality through his work as the head of Johnson & Johnson’s venture capital division, which invests in dozens of companies each year. He shares what’s on his radar for 2019.
Caring & giving around the globe: 43 Johnson & Johnson programs that are transforming lives—and the future of healthcare
Check out this fun interactive map for a glimpse at how the company is helping people on nearly every continent live healthier lives.
Doing good day and night: 6 Johnson & Johnson employees who are making the world a better place
Who says you can’t take your work home with you? For these men and women, their day jobs are just one facet of living a purpose-driven life to help others in truly impactful ways.